Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 May;113(5):645-57.
doi: 10.1007/s00702-005-0352-y. Epub 2005 Oct 27.

Lack of glutathione peroxidase-1 exacerbates Abeta-mediated neurotoxicity in cortical neurons

Affiliations
Comparative Study

Lack of glutathione peroxidase-1 exacerbates Abeta-mediated neurotoxicity in cortical neurons

P J Crack et al. J Neural Transm (Vienna). 2006 May.

Abstract

The aetiologies of Alzheimer's disease (AD) are complex and multifactorial. Current therapies are largely ineffective, as the pathophysiological pathways are poorly understood. Observations in AD autopsies, as well as in vivo and in vitro observations in transgenic mice, have implicated oxidative stress as pathogenic in AD. This study used the Glutathione Peroxidase-1 knockout mouse (Gpx1--/--) model to investigate the role of antioxidant disparity in neuropathologies. Cultured neurons from control and Gpx1--/-- embryos were treated with AD-related peptides and the degree of cell loss compared. Results show that antioxidant disparity makes Gpx1--/-- cells more susceptible to Abeta toxicity. Surrogate replacement of Gpx1 with the reactive oxygen species scavenger N-acetyl cysteine and the Gpx1 mimetic ebselen, reverses the Gpx1--/-- increased susceptibility to Abeta toxicity. Such results support a role for oxidative stress in AD-related neuronal loss. This study is the first to report such findings using the Gpx1--/-- model, and supports a role for oxidative stress as one of the contributing factors, in development of AD-like pathologies.

PubMed Disclaimer

References

    1. Neurobiol Dis. 2000 Aug;7(4):395-405 - PubMed
    1. J Neurochem. 1995 Jul;65(1):218-27 - PubMed
    1. J Biol Chem. 1998 Aug 28;273(35):22528-36 - PubMed
    1. Clin Exp Pharmacol Physiol. 2004 Jul;31(7):397-406 - PubMed
    1. Free Radic Res. 1999 Oct;31(4):261-72 - PubMed

Publication types

MeSH terms

LinkOut - more resources